The Best Laser for Melasma on Darker Skin

Finding the best laser for melasma on darker skin is not straightforward, and the stakes are real. Melasma is a chronic pigmentation disorder driven by UV exposure, hormonal fluctuations, and heat, and it disproportionately affects people with Fitzpatrick skin types IV through VI. The same melanocytes that overproduce pigment in melasma patches are also highly reactive to injury, meaning an aggressive laser that clears pigment in a fair-skinned patient can trigger severe post-inflammatory hyperpigmentation (PIH) in a darker-skinned patient, leaving the skin worse than before treatment.

Understanding why certain lasers are safer starts with understanding the mechanism of melanin targeting. Most pigment-focused lasers rely on selective photothermolysis, the principle that a specific wavelength is absorbed preferentially by melanin while sparing surrounding tissue. The problem for darker skin types is that epidermal melanin is abundant throughout the skin, not just in melasma patches, so shorter wavelengths with high epidermal absorption create a high collision risk with healthy pigment cells outside the target zone.

The 1064 nm Nd:YAG laser is widely regarded as the most appropriate energy-based option for melasma in darker skin. At 1064 nanometers, the wavelength penetrates more deeply into the dermis and is absorbed less aggressively by epidermal melanin compared to shorter wavelengths like 532 nm or 694 nm. This relative sparing of the epidermis reduces, though does not eliminate, the risk of PIH. Low-fluence, high-repetition Nd:YAG protocols, sometimes called laser toning, deliver sub-ablative energy across the treatment zone in multiple rapid passes. The goal is a gradual photothermal effect that disperses melanin-containing melanosomes without fully destroying the melanocyte, which could trigger an inflammatory cascade.

Results from laser toning are incremental. Most clinical protocols involve six to ten sessions spaced two to four weeks apart. Patients typically see measurable lightening after the third or fourth session, but full assessment requires completing the series. Importantly, melasma is a chronic condition and not a curable one. Laser treatment suppresses pigment production and clears existing deposits, but without strict sun protection and often topical maintenance such as hydroquinone, tranexamic acid, or azelaic acid, recurrence is common within months.

Q-switched Nd:YAG devices, which deliver energy in nanosecond pulses, and newer picosecond lasers operating at 1064 nm are also used in this population. Picosecond technology generates a photoacoustic rather than purely photothermal effect, theoretically fragmenting pigment with less heat deposited in surrounding tissue. Early data in darker skin types is cautiously optimistic, but picosecond treatments at 532 nm or 755 nm still carry meaningful PIH risk in Fitzpatrick IV and above and should be approached carefully. For a deeper clinical breakdown of how these devices are applied in practice, consult a dermatologist who treats melasma regularly.

Fractional non-ablative lasers at 1550 nm or 1927 nm have a more complicated relationship with melasma in darker skin. While they are used in some protocols to address the dermal component of mixed melasma, the thermal injury they create can stimulate melanocyte activity. They require experienced hands and conservative settings. Ablative fractional lasers, including CO2 and Er:YAG, are generally not recommended as primary melasma treatments in darker skin types due to substantial PIH risk. For related context, see our note on Vbeam vs IPL for Facial Redness: How These Treatments Compare.

Candidate selection matters as much as device selection. Before any laser treatment, a clinician should assess the depth of pigmentation, ideally using a Wood's lamp or reflectance confocal microscopy where available. Purely epidermal melasma responds better to laser treatment than mixed or dermal forms. A trial of topical therapy for eight to twelve weeks before any laser intervention is a reasonable first step, both to prime the skin and to gauge melanocyte reactivity.

Downtime with low-fluence Nd:YAG laser toning is minimal, typically mild erythema that resolves within hours to a day. The tradeoff is that these conservative protocols require more sessions to achieve results. Higher-fluence approaches compress the timeline but increase the risk profile considerably in darker skin tones.

Cost varies by market, provider, and device. Individual Nd:YAG laser toning sessions typically range from 150 to 400 dollars per treatment. A full series of eight sessions could total 1200 to 3200 dollars. Picosecond sessions tend to run higher, roughly 300 to 600 dollars per treatment, reflecting equipment costs. Neither is covered by insurance, as melasma treatment is classified as cosmetic.

The honest clinical picture is this: laser treatment can meaningfully improve melasma in darker skin, but it is not a first-line intervention for everyone and it is not a permanent fix. It works best as one component of a broader management strategy that includes rigorous sun protection, topical agents, and realistic expectations about maintenance. The device matters, the settings matter, and the experience of the treating clinician matters perhaps most of all.

Related reading: Microneedling vs Fractional Laser for Acne Scars: How They Work and What to Expect, CO2 laser vs erbium resurfacing, compared.